Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312341 | SCV000846439 | benign | Inborn genetic diseases | 2016-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001692265 | SCV001913735 | benign | not provided | 2018-07-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001692265 | SCV002396333 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499303 | SCV002807474 | benign | Wieacker-Wolff syndrome; Wieacker-Wolff syndrome, female-restricted | 2021-08-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001692265 | SCV005279375 | benign | not provided | criteria provided, single submitter | not provided |